4//SEC Filing
Ballance David James 4
Accession 0001209191-18-062939
CIK 0001169245other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:24 PM ET
Size
4.8 KB
Accession
0001209191-18-062939
Insider Transaction Report
Form 4
Ballance David James
VP, Research and Sci. Affairs
Transactions
- Purchase
Common Stock
2018-12-13$3.94/sh+1,000$3,940→ 7,600 total
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001755432
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:24 PM ET
- Size
- 4.8 KB